Table 2.
Summary of results from all interventions and parameters measured.
| Calf Circumference | EV (mL) | P Versus. <35 cm | PV (cm/s) | P Versus. <35 cm | TAMEAN (cm/s) | P Versus. <35 cm |
|---|---|---|---|---|---|---|
|
<35 cm
Baseline |
18.05 ± 7.7 | 17.16 ± 3.8 | 3.99 ± 0.9 | |||
|
<35 cm
Voluntary Contraction |
27.63 ± 7.5 | P = 0.0280 | 70.28 ± 12.7 | P < 0.0001 | 5.98 ± 1.2 | P < 0.0088 |
|
<35 cm
NUIG |
21.46 ± 6.7 | P = 0.8166 | 54.55 ± 23.7 | P = 0.0012 | 5.30 ± 1.01 | P = 0.2560 |
|
<35 cm
GekoTM |
17.55 ± 3.7 | P = 0.9994 | 61.72 ± 22.9 | P < 0.0001 | 4.66 ± 2.2 | P = 0.8095 |
|
>35 cm
Baseline |
18.8 ± 9.1 | 18.21 ± 5.1 | 3.42 ± 1.1 | |||
|
>35 cm
Voluntary Contraction |
33.93 ± 10.6 | P = 0.0119 | 81.60 ± 13.5 | P < 0.0001 | 6.05 ± 1.4 | P = 0.0004 |
|
>35 cm
NUIG |
24.41 ± 9.4 | P = 0.7355 | 66.45 ± 19.2 | P < 0.0001 | 4.57 ± 1.4 | P = 0.3388 |
|
>35 cm
GekoTM |
28.74 ± 11.7 | P = 0.4444 | 40.04 ± 14.6 | P = 0.0627 | 4.06 ± 1.8 | P = 0.8590 |
Ejected volume (EV), peak venous velocity (PV), and timed average velocity (TAMEAN) represented in subgroups for 12-s measurement windows. P-value versus baseline for intervention subgroup. P-value versus mean ± standard deviation.